Incyte Ebit vs Income Before Tax Analysis

INCY Stock

USD 57.05 0.55 0.95%

Incyte financial indicator trend analysis is infinitely more than just investigating Incyte recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Incyte is a good investment. Please check the relationship between Incyte Ebit and its Income Before Tax accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Ebit vs Income Before Tax

Ebit vs Income Before Tax Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Incyte Ebit account and Income Before Tax. At this time, the significance of the direction appears to have totally related.

The correlation between Incyte's Ebit and Income Before Tax is 1.0. Overlapping area represents the amount of variation of Ebit that can explain the historical movement of Income Before Tax in the same time period over historical financial statements of Incyte, assuming nothing else is changed. The correlation between historical values of Incyte's Ebit and Income Before Tax is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Ebit of Incyte are associated (or correlated) with its Income Before Tax. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Income Before Tax has no effect on the direction of Ebit i.e., Incyte's Ebit and Income Before Tax go up and down completely randomly.

Correlation Coefficient

1.0

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Ebit

Income Before Tax

Income Before Tax which can also be referred as pre-tax income is reported on Incyte income statement and is an important metric when analyzing Incyte profitability. Accounting techniques because taxes can be complex, and not perfectly consistent from one company to company, an analyst may use pre-tax income as a more stable measure of profitability.

Most indicators from Incyte's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Incyte current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.At this time, Incyte's Selling General Administrative is fairly stable compared to the past year. Tax Provision is likely to rise to about 229.8 M in 2024, whereas Sales General And Administrative To Revenue is likely to drop 0.30 in 2024.

	2021	2022	2023	2024 (projected)
Total Operating Expenses	2.2B	2.6B	2.8B	2.9B
Cost Of Revenue	151.0M	207.0M	255M	267.8M

Total Operating Expenses Cost Of Revenue

Incyte fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Non Currrent Assets Other	Net Receivables	Property Plant And Equipment Gross	Intangible Assets	Short Term Investments	Other Assets	Long Term Debt
Total Assets		-0.58	0.35	0.8	0.99	0.98	-0.98	0.64	0.79	0.99	0.99	0.99	0.52	-0.25	0.99	0.93	0.87	1.0	-0.39	0.85	0.99	0.99	0.39	0.92	0.88	-0.67
Short Long Term Debt Total	-0.58		0.14	-0.17	-0.67	-0.62	0.7	-0.5	-0.49	-0.56	-0.6	-0.56	-0.12	0.87	-0.61	-0.59	-0.15	-0.57	0.69	-0.35	-0.62	-0.6	-0.39	-0.54	-0.44	0.98
Other Current Liab	0.35	0.14		0.63	0.3	0.36	-0.31	0.14	0.68	0.37	0.31	0.37	0.45	0.34	0.3	0.3	0.55	0.37	0.26	0.12	0.33	0.28	0.29	0.26	0.33	0.09
Total Current Liabilities	0.8	-0.17	0.63		0.74	0.76	-0.71	0.47	0.69	0.78	0.8	0.79	0.51	0.18	0.75	0.7	0.93	0.79	0.22	0.69	0.78	0.78	0.4	0.74	0.72	-0.24
Total Stockholder Equity	0.99	-0.67	0.3	0.74		0.98	-0.99	0.66	0.78	0.98	0.98	0.99	0.48	-0.35	0.98	0.93	0.81	0.99	-0.46	0.83	0.99	0.99	0.39	0.92	0.87	-0.74
Property Plant And Equipment Net	0.98	-0.62	0.36	0.76	0.98		-0.96	0.59	0.84	0.96	0.98	0.96	0.55	-0.3	0.99	0.94	0.83	0.97	-0.43	0.76	0.99	0.98	0.42	0.89	0.84	-0.71
Net Debt	-0.98	0.7	-0.31	-0.71	-0.99	-0.96		-0.66	-0.8	-0.98	-0.96	-0.98	-0.48	0.41	-0.97	-0.92	-0.78	-0.98	0.5	-0.81	-0.97	-0.97	-0.38	-0.88	-0.86	0.78
Retained Earnings	0.64	-0.5	0.14	0.47	0.66	0.59	-0.66		0.39	0.65	0.63	0.63	-0.25	-0.47	0.62	0.34	0.43	0.63	-0.37	0.73	0.62	0.68	-0.13	0.45	0.85	-0.45
Accounts Payable	0.79	-0.49	0.68	0.69	0.78	0.84	-0.8	0.39		0.78	0.77	0.78	0.61	-0.22	0.81	0.79	0.71	0.79	-0.29	0.43	0.8	0.74	0.47	0.65	0.68	-0.57
Cash	0.99	-0.56	0.37	0.78	0.98	0.96	-0.98	0.65	0.78		0.97	1.0	0.49	-0.25	0.97	0.91	0.87	1.0	-0.4	0.87	0.97	0.98	0.32	0.89	0.89	-0.64
Non Current Assets Total	0.99	-0.6	0.31	0.8	0.98	0.98	-0.96	0.63	0.77	0.97		0.97	0.5	-0.25	0.98	0.93	0.86	0.98	-0.38	0.83	0.99	0.99	0.44	0.92	0.87	-0.68
Cash And Short Term Investments	0.99	-0.56	0.37	0.79	0.99	0.96	-0.98	0.63	0.78	1.0	0.97		0.51	-0.23	0.97	0.93	0.88	1.0	-0.39	0.87	0.97	0.98	0.35	0.92	0.88	-0.65
Common Stock Shares Outstanding	0.52	-0.12	0.45	0.51	0.48	0.55	-0.48	-0.25	0.61	0.49	0.5	0.51		0.24	0.52	0.72	0.6	0.52	0.01	0.19	0.52	0.45	0.64	0.6	0.19	-0.28
Non Current Liabilities Total	-0.25	0.87	0.34	0.18	-0.35	-0.3	0.41	-0.47	-0.22	-0.25	-0.25	-0.23	0.24		-0.31	-0.21	0.21	-0.25	0.68	-0.14	-0.29	-0.28	0.04	-0.15	-0.27	0.8
Other Current Assets	0.99	-0.61	0.3	0.75	0.98	0.99	-0.97	0.62	0.81	0.97	0.98	0.97	0.52	-0.31		0.93	0.84	0.98	-0.45	0.82	0.98	0.98	0.36	0.89	0.88	-0.7
Other Stockholder Equity	0.93	-0.59	0.3	0.7	0.93	0.94	-0.92	0.34	0.79	0.91	0.93	0.93	0.72	-0.21	0.93		0.81	0.93	-0.4	0.68	0.94	0.91	0.55	0.93	0.68	-0.71
Total Liab	0.87	-0.15	0.55	0.93	0.81	0.83	-0.78	0.43	0.71	0.87	0.86	0.88	0.6	0.21	0.84	0.81		0.87	0.01	0.8	0.84	0.85	0.36	0.82	0.78	-0.27
Total Current Assets	1.0	-0.57	0.37	0.79	0.99	0.97	-0.98	0.63	0.79	1.0	0.98	1.0	0.52	-0.25	0.98	0.93	0.87		-0.4	0.86	0.98	0.99	0.36	0.92	0.88	-0.66
Short Term Debt	-0.39	0.69	0.26	0.22	-0.46	-0.43	0.5	-0.37	-0.29	-0.4	-0.38	-0.39	0.01	0.68	-0.45	-0.4	0.01	-0.4		-0.31	-0.42	-0.41	-0.03	-0.31	-0.35	0.71
Non Currrent Assets Other	0.85	-0.35	0.12	0.69	0.83	0.76	-0.81	0.73	0.43	0.87	0.83	0.87	0.19	-0.14	0.82	0.68	0.8	0.86	-0.31		0.82	0.88	0.02	0.77	0.87	-0.42
Net Receivables	0.99	-0.62	0.33	0.78	0.99	0.99	-0.97	0.62	0.8	0.97	0.99	0.97	0.52	-0.29	0.98	0.94	0.84	0.98	-0.42	0.82		0.99	0.39	0.91	0.87	-0.7
Property Plant And Equipment Gross	0.99	-0.6	0.28	0.78	0.99	0.98	-0.97	0.68	0.74	0.98	0.99	0.98	0.45	-0.28	0.98	0.91	0.85	0.99	-0.41	0.88	0.99		0.33	0.91	0.9	-0.67
Intangible Assets	0.39	-0.39	0.29	0.4	0.39	0.42	-0.38	-0.13	0.47	0.32	0.44	0.35	0.64	0.04	0.36	0.55	0.36	0.36	-0.03	0.02	0.39	0.33		0.51	0.02	-0.44
Short Term Investments	0.92	-0.54	0.26	0.74	0.92	0.89	-0.88	0.45	0.65	0.89	0.92	0.92	0.6	-0.15	0.89	0.93	0.82	0.92	-0.31	0.77	0.91	0.91	0.51		0.7	-0.63
Other Assets	0.88	-0.44	0.33	0.72	0.87	0.84	-0.86	0.85	0.68	0.89	0.87	0.88	0.19	-0.27	0.88	0.68	0.78	0.88	-0.35	0.87	0.87	0.9	0.02	0.7		-0.48
Long Term Debt	-0.67	0.98	0.09	-0.24	-0.74	-0.71	0.78	-0.45	-0.57	-0.64	-0.68	-0.65	-0.28	0.8	-0.7	-0.71	-0.27	-0.66	0.71	-0.42	-0.7	-0.67	-0.44	-0.63	-0.48

Click cells to compare fundamentals

Incyte Account Relationship Matchups

Incyte fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	3.4B	3.6B	4.9B	5.8B	6.8B	7.1B
Short Long Term Debt Total	50.9M	34.9M	34.3M	44.6M	38.3M	36.4M
Other Current Liab	76.1M	86.2M	82.8M	469.7M	111.7M	70.6M
Total Current Liabilities	500.5M	648.8M	885.1M	1.2B	1.2B	1.3B
Total Stockholder Equity	2.6B	2.6B	3.8B	4.4B	5.2B	5.4B
Property Plant And Equipment Net	406.6M	588.1M	751.5M	765.6M	777.0M	815.9M
Net Debt	(1.8B)	(1.5B)	(2.0B)	(2.9B)	(3.2B)	(3.0B)
Retained Earnings	(1.4B)	(1.7B)	(777.9M)	(437.2M)	160.4M	168.4M
Accounts Payable	83.6M	98.8M	172.1M	277.5M	109.6M	115.1M
Cash	1.8B	1.5B	2.1B	3.0B	3.2B	3.4B
Non Current Assets Total	889.7M	1.1B	1.7B	1.6B	2.1B	2.2B
Cash And Short Term Investments	2.1B	1.8B	2.3B	3.2B	3.7B	3.8B
Common Stock Shares Outstanding	217.7M	218.1M	222.1M	224.0M	225.9M	130.7M
Liabilities And Stockholders Equity	3.4B	3.6B	4.9B	5.8B	6.8B	7.1B
Non Current Liabilities Total	327.9M	300.9M	278.3M	254.3M	351.9M	340.4M
Other Current Assets	94.2M	103.3M	165.3M	167.0M	182.8M	192.0M
Other Stockholder Equity	4.0B	4.4B	4.6B	4.8B	5.0B	5.3B
Total Liab	828.3M	949.7M	1.2B	1.5B	1.6B	1.7B
Total Current Assets	2.5B	2.4B	3.2B	4.2B	4.6B	4.9B
Short Term Debt	28.3M	15.0M	13.2M	11.4M	9.1M	8.7M
Non Currrent Assets Other	55.6M	62.8M	68.1M	106.1M	260.9M	274.0M
Net Receivables	308.8M	482.0M	616.3M	644.9M	743.6M	780.7M
Property Plant And Equipment Gross	406.6M	559.6M	751.5M	765.6M	1.0B	1.1B
Accumulated Other Comprehensive Income	(15.5M)	(15.4M)	(19.5M)	15.1M	13.1M	13.8M
Intangible Assets	193.8M	172.3M	150.8M	129.2M	123.5M	74.2M
Short Term Investments	284.9M	288.4M	290.8M	287.5M	442.7M	464.8M
Other Assets	55.6M	25.1M	467.5M	564.0M	648.6M	681.1M
Common Stock Total Equity	216K	219K	221K	223K	256.5K	154K
Common Stock	216K	219K	221K	223K	224K	157.9K
Property Plant Equipment	377.6M	559.6M	723.9M	739.3M	850.2M	892.7M
Current Deferred Revenue	312.4M	448.9M	617.0M	457.9M	1.0B	1.1B
Other Liab	271.2M	266M	244M	269.6M	310.0M	156.9M
Inventory	16.5M	36.0M	56.9M	121.0M	63.0M	66.1M
Net Tangible Assets	2.2B	2.3B	3.5B	4.1B	4.7B	4.9B
Retained Earnings Total Equity	(1.4B)	(1.7B)	(777.9M)	(437.2M)	(502.8M)	(527.9M)
Capital Surpluse	4.0B	4.4B	4.6B	4.8B	5.5B	3.4B
Non Current Liabilities Other	315.0M	318.5M	309.0M	313.8M	322.7M	278.6M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

C	Citigroup
CRM	Salesforce
MSFT	Microsoft

When determining whether Incyte offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Incyte's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Incyte Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Incyte Stock:

How To Invest In Incyte

Details

Is Incyte Stock a good investment?

Details

What is Incyte's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Incyte. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in main economic indicators.

For more information on how to buy Incyte Stock please use our How to Invest in Incyte guide.

Note that the Incyte information on this page should be used as a complementary analysis to other Incyte's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Incyte Stock analysis

When running Incyte's price analysis, check to measure Incyte's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Incyte is operating at the current time. Most of Incyte's value examination focuses on studying past and present price action to predict the probability of Incyte's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Incyte's price. Additionally, you may evaluate how the addition of Incyte to your portfolios can decrease your overall portfolio volatility.

	Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
	Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Transaction History View history of all your transactions and understand their impact on performance
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	FinTech Suite Use AI to screen and filter profitable investment opportunities

Is Incyte's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Incyte. If investors know Incyte will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Incyte listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

6.705

Earnings Share

3.3

Revenue Per Share

16.82

Quarterly Revenue Growth

0.089

Return On Assets

0.0689

The market value of Incyte is measured differently than its book value, which is the value of Incyte that is recorded on the company's balance sheet. Investors also form their own opinion of Incyte's value that differs from its market value or its book value, called intrinsic value, which is Incyte's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Incyte's market value can be influenced by many factors that don't directly affect Incyte's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Incyte's value and its price as these two are different measures arrived at by different means. Investors typically determine if Incyte is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Incyte's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Incyte Ebit vs Income Before Tax Analysis

Ebit vs Income Before Tax

Ebit vs Income Before Tax Correlation Analysis

Correlation Coefficient

Ebit

Income Before Tax

Incyte fundamental ratios Correlations

Incyte Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Incyte fundamental ratios Accounts

Also Currently Popular

Complementary Tools for Incyte Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Assets	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash
Total Current Assets	+ 1.0	Cash And Short Term Investments
Total Stockholder Equity	+ 0.99	Total Assets
Cash	+ 0.99	Total Assets

Net Debt	- 0.99	Total Stockholder Equity
Total Current Assets	- 0.98	Net Debt
Cash And Short Term Investments	- 0.98	Net Debt
Cash	- 0.98	Net Debt
Net Debt	- 0.98	Total Assets
Property Plant And Equipment Gross	- 0.97	Net Debt